Costañera, Lloyd D.

HRN: 28-93-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CO-AMOXICLAV 625MG (TAB)
05/03/2026
05/10/2026
PO
625mg
BID
Multiple Abrasions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: